Literature DB >> 22988094

Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.

Rika Ouchida1, Hiromi Mori, Koji Hase, Hiroyuki Takatsu, Tomohiro Kurosaki, Takeshi Tokuhisa, Hiroshi Ohno, Ji-Yang Wang.   

Abstract

IgM antibodies have been known for decades to enhance humoral immune responses in an antigen-specific fashion. This enhancement has been thought to be dependent on complement activation by IgM-antigen complexes; however, recent genetic studies render this mechanism unlikely. Here, we describe a likely alternative explanation; mice lacking the recently identified Fc receptor for IgM (FcμR) on B cells produced significantly less antibody to protein antigen during both primary and memory responses. This immune deficiency was accompanied by impaired germinal center formation and decreased plasma and memory B-cell generation. FcμR did not affect steady-state B-cell survival but specifically enhanced the survival and proliferation induced by B-cell receptor cross-linking. Moreover, FcμR-deficient mice produced far more autoantibodies than control mice as they aged, suggesting that FcμR is also required for maintaining tolerance to self-antigens. Our results thus define a unique pathway mediated by the FcμR for regulating immunity and tolerance and suggest that IgM antibodies promote humoral immune responses to foreign antigen yet suppress autoantibody production through at least two pathways: complement activation and FcμR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988094      PMCID: PMC3479561          DOI: 10.1073/pnas.1210706109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire.

Authors:  Y Takahashi; H Ohta; T Takemori
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  Role of antigen receptor affinity in T cell-independent antibody responses in vivo.

Authors:  Tien-An Yang Shih; Mario Roederer; Michel C Nussenzweig
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

4.  Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.

Authors:  Y Hitoshi; J Lorens; S I Kitada; J Fisher; M LaBarge; H Z Ring; U Francke; J C Reed; S Kinoshita; G P Nolan
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

5.  Reduction of marginal zone B cells in CD22-deficient mice.

Authors:  Tatjana Samardzic; Dragan Marinkovic; Claus-Peter Danzer; Judith Gerlach; Lars Nitschke; Thomas Wirth
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

6.  Requirement for B cell linker protein (BLNK) in B cell development.

Authors:  R Pappu; A M Cheng; B Li; Q Gong; C Chiu; N Griffin; M White; B P Sleckman; A C Chan
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

7.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

8.  Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Yoshiki Kubagawa; Matthew K McCollum; Landon Wilson; Tomoko Motohashi; Luigi F Bertoli; James C Barton; Stephen Barnes; Randall S Davis; Hiromi Kubagawa
Journal:  Blood       Date:  2011-09-09       Impact factor: 22.113

9.  Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies.

Authors:  M R Ehrenstein; H T Cook; M S Neuberger
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  Essential immunoregulatory role for BCAP in B cell development and function.

Authors:  Tetsuo Yamazaki; Kiyoshi Takeda; Kumiko Gotoh; Hiroshi Takeshima; Shizuo Akira; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  50 in total

Review 1.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

2.  Early Detection of Circulating Antigen and IgM-Associated Immune Complexes during Experimental Mycobacterium bovis Infection in Cattle.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Alina Sikar-Gang; Archana A Sridhara; Ashley Johnathan; Paul Lambotte; Javan Esfandiari; Mayara F Maggioli; Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 3.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

Review 4.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

5.  Immunoglobulins drive terminal maturation of splenic dendritic cells.

Authors:  Natalia Zietara; Marcin Łyszkiewicz; Jacek Puchałka; Gang Pei; Maximiliano Gabriel Gutierrez; Stefan Lienenklaus; Elias Hobeika; Michael Reth; Vitor A P Martins dos Santos; Andreas Krueger; Siegfried Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

Review 6.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

7.  Designed IgM from glycoengineering.

Authors:  Andrew Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-15       Impact factor: 11.205

8.  Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice.

Authors:  Christopher S Wilson; Preeti Chhabra; Andrew F Marshall; Caleigh V Morr; Blair T Stocks; Emilee M Hoopes; Rachel H Bonami; Greg Poffenberger; Kenneth L Brayman; Daniel J Moore
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

9.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

10.  Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Yusuke Suzuki; Miyuki Takagi; Hiroshi Ohno; R Pat Bucy; Shozo Izui; Hiromi Kubagawa
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.